http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-9809092-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b9dc89cc4ba060cc73bbf0c90bbb78
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501
filingDate 1998-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eba079f32bcbec4cc344ea121dc53381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_123b8ffcaf5460cda2002f105db51a95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_123e73e40f33cd0f4b9dbb3faea3fa9d
publicationDate 2002-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-9809092-A
titleOfInvention Indole derivatives having combined 5ht1a, 5ht1b and 5ht1d receptor antagonist activity
abstract "INDOL DERIVATIVES HAVING COMBINED ACTIVITY OF 5HT1A, 5HT1B AND 5HT1D RECEPTOR ANTAGONIST". The present invention relates to compounds of formula (I), processes for their preparation and use as CNS agents, where R ^ a ^ is a group of formula (i), where P ^ 1 ^ is a phenyl , bicyclic aryl, a heterocyclic ring containing from 5 to 7 members containing from 1 to 3 heteroatoms selected from oxygen, nitrogen and sulfur, or a bicyclic heterocyclic ring containing from 1 to 3 heteroatoms selected from oxygen, nitrogen and sulfur; R ^ 1 ^ is hydrogen, halogen, C ~ 1-6 ~ alkyl, C ~ 3-6 ~ cycloalkyl, C ~ 1-6 ~ alkyl, C ~ 1-6 ~ alkoxy, hydroxy, C ~ 1-6 alkyl hydroxy ~, C ~ 1-6 ~ alkoxy hydroxide, C ~ 1-6 alkoxy, C ~ 1-6 ~ alkoxy, C ~ 1-6 ~ alkanoyl, nitro, methyl trifluor, cyano, SR ^ 9 ^, SOR ^ 9 ~ , SO ~ 2 ~ R ^ 9 ^, SO ~ 2 ~ NR ^ 10 ^ R ^ 11 ^, CO ~ 2 ~ R ^ 10 ^, CONR ^ 10 ^ R ^ 11 ^, CO ~ 2 ~ NR ^ 10 ^ R ^ 11 ^ CONR ^ 10 ^ (CH ~ 2 ~) ~ c ~ CO ~ 2 ~ R ^ 11 ^, (CH ~ 2 ~) ~ c ~ NR ^ 10 ^ R ^ 11 ^, (CH ~ 2 ~) ~ c ~ CONR ^ 10 ^ R ^ 11 ^, (CH ~ 2 ~) ~ c ~ NR ^ 10 ^ R ^ 11 ^, (CH ~ 2 ~) ~ c ~ CO ~ 2 ~ C ~ 1-6 ~ alkyl, CO ~ 2 ~ (CH ~ 2 ~) ~ c ~ OR ^ 10 ^, NR ^ 10 ^ OR ^ 11 ^, NR ^ 10 ^ CO ~ 2 ~ R ^ 11 ^, NR ^ 10 ^ CONR ^ 10 ^ R ^ 11 ^, CR ^ 11 ^ = NOR ^ 11 ^, NR ^ 10 ^ COOR ^ 11 ^, CNR ~ 10 ^ = NOR ^ 11 ^, where R ^ 10 ^ and R ^ 11 ^ are independently hydrogen or C ~ 1 alkyl -6 ~ ec is 1 to 4; R ^ 2 ^ is hydrogen, halogen, C ^ 1-6 ^ alkyl, C ~ 3-6 ~ cycloalkyl, C ~ 3-6 ~ cycloalkyl, C ~ 1-6 ~ alkoxy, acyl, aryl, acyloxy, hydroxy, nitro , trifluoromethyl, cyano, CO ~ 2 ~ R ^ 10 ^, CONR ^ 10 ^ R ^ 11 ^, NR ^ 10 ^ R ^ 11 ^, where R ^ 10 ^ and R ^ 11 ^ are as defined for R ^ 1 ^ ; a is 1, 2 or 3; or R ^ a ^ is a group of formula (ii), in which p ^ 2 ^ and P ^ 3 ^ are independently phenyl, bicyclic aryl, a 5- to 7-membered heterocyclic ring containing from 1 to 3 heteroatoms selected from oxygen, nitrogen and sulfur, or a bicyclic heterocyclic group containing from 1 to 3 heteroatoms selected from oxygen, nitrogen or sulfur; A is a bond or oxygen, S (O) ~ m ~ where m is 0 to 2, carbonyl, CH ~ 2 ~ or NR ^ 4 ^ ~ where R ^ 4 ^ is hydrogen or C ~ 1-6 ~ alkyl; R ^ 1 ^ is as defined above for formula (I) or R ^ 1 ^ is an optionally substituted 5- to 7-membered heterocyclic ring containing 1 to 3 selected heteroatoms of oxygen, nitrogen or sulfur; R ^ 2 ^ and R ^ 3 ^ are independently hydrogen, halogen, C ~ 1-6 ~ alkyl, C ~ 3-6 ~ cycloalkyl, C ~ 3-6 ~ cycloalkenyl, C ~ 1-6 ~ alkoxy, acyl, aryl , acyloxy, hydroxy, nitro, trifluoromethyl, cyano, CO ~ 2 ~ R ^ 10 ^, CONR ^ 10 ^ R ^ 11 ^, NR ^ 10 ^ R ^ 11 ^, where R ^ 10 ^ and R ^ 11 ^ are like defined for R ^ 1 ^; and a and b are, independently, 1, 2 or 3; Y is -NH-, NR ^ 5 ^, where R ^ 5 ^ is C ~ 1-6 ~ alkyl, or Y is -CH ~ 2 ~ or -O-; V is oxygen or sulfur; D is nitrogen, carbon or a CH group; W is (CR ^ 16 ^ R ^ 17 ^) ~ t ~, where t is 2, 3 or 4 and R ^ 16 ^ and R ^ 17 ^ are independently hydrogen or C ~ 1-6 ~ alkyl or W is (CR ^ 16 ~ R ~ 17 ~) ~ u ~ - J, where u is 0, 1, 2 or 3 and J is oxygen, sulfur, CR ^ 16 ^ = CR ^ 17 ^, CR ^ 16 ^ = N, = CR ^ 16 ^ O, = CR ^ 16 ^ S or = CR ^ 16 ^ -NR ^ 17 ^; X is nitrogen or carbon; R ^ b ^ is hydrogen, halogen, hydroxy, C ~ 1-6 ~ alkyl, trifluoromethyl, C ~ 1-6 ~ alkoxy, C ~ 2-6 ~ alkenyl, C ~ 3-7 ~ cycloalkyl optionally substituted by C ~ alkyl 1-4 ~ or aryl; R ^ c ^ is hydrogen or C ~ 1-6 ~ alkyl; and <sym> is a single bond when X is nitrogen or a single or double bond when X is carbon.
priorityDate 1997-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407208027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581

Total number of triples: 61.